St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

Description

This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.

Conditions

Cervical Cancer Screening

Study Overview

Study Details

Study overview

This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.

Increasing Cancer Screening Among Female Patients At PSH St. Joseph's Residency Clinic: Offering a Self-sampling Option in Clinic

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

Condition
Cervical Cancer Screening
Intervention / Treatment

-

Contacts and Locations

Reading

Penn State Health St. Joseph's, Reading, Pennsylvania, United States, 19605

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Eligible but out-of-date for cervical cancer screening
  • * Able to speak, read, and communicate well in English or Spanish
  • * Not at greater than average risk for cervical cancer
  • * Pregnant
  • * Incarcerated
  • * Greater than average risk for cervical cancer, for example:
  • * Already diagnosed with high-grade precancerous cervical cancer or cervical lesions
  • * Has a compromised immune system
  • * Unable to speak, read, and communicate well in English or Spanish
  • * Unable or unwilling to give implied consent or otherwise complete study requirements

Ages Eligible for Study

30 Years to 65 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Milton S. Hershey Medical Center,

Christina Scartozzi, DO, PRINCIPAL_INVESTIGATOR, Penn State College of Medicine

Study Record Dates

2025-06-30